#USA #Center Valley #Olympus #BPH #iTind

Olympus Expands iTind Center of Excellence Program

Olympus Corp. of the Americas has recently announced the introduction of new members into its iTind™ Center of Excellence (COE) Program, aimed at significantly advancing the treatment experience for men dealing with benign prostatic hyperplasia (BPH), commonly known as enlarged prostate. This program aims to enhance patient care through a network of specialist urologists who are committed to excellence in BPH management.

New Members of the COE Program

The program now includes esteemed urologists such as:

• - John Klein, MD from Potomac Urology
• - Tyler McClintock, MD from Midtown Urology Associates
• - Richard Roach, MD from the Advanced Urology Institute

To qualify for the iTind Center of Excellence, urologists must complete a specialized training program, exhibit experience with the iTind procedure, and demonstrate unwavering dedication to improving the quality of care for their patients. Notably, all members must undergo an annual re-certification process to maintain their COE status, ensuring they remain updated with the latest practices and advancements in the field.

Importance of iTind in BPH Treatment

During National Prostate Health Month in September, Matt Woodward, Vice President and Regional Business Lead for Urology at Olympus, emphasized the significance of the iTind Center of Excellence: “BPH affects approximately 50% of men in their fifties, creating a range of symptoms that can severely impact quality of life. By ensuring that patients know about safe and effective treatment options, we are enhancing their overall experience and outcomes.”

The iTind procedure provides a minimally invasive alternative for men suffering from BPH symptoms without requiring cutting or tissue removal. The treatment includes the insertion and removal of a temporary nitinol device, which aims to alleviate urinary complications while preserving sexual and ejaculatory functions.

The iTind Procedure Explained

The iTind™ Procedure is specifically designed to address lower urinary tract symptoms that stem from BPH. It offers rapid relief in symptoms for most patients, making it an appealing choice for those who prefer non-pharmaceutical approaches or are not ready to undergo surgery. The procedure can be performed in an outpatient setting, allowing patients to return home the same day without the need for catheterization.

Clinical Evidence and Benefits

Clinical studies have consistently shown the effectiveness and efficiency of the iTind procedure in treating BPH symptoms. By employing this treatment, physicians can reduce the discomfort and complications typically associated with standard surgical interventions, as complications like urinary tract infections are rare. The procedure is tailored for men over 50 years of age, who are generally experiencing urinary outflow obstruction due to BPH.

For informed decision-making regarding BPH treatment, physicians can be found using the iTind Physician Finder, connecting patients with certified specialists committed to improving their urinary health through minimally invasive solutions.

About Olympus

Headquartered in Center Valley, Pennsylvania, Olympus Corporation of the Americas is dedicated to enriching lives through innovative medical technology. The company partners with healthcare professionals to offer optimal solutions for early detection, diagnosis, and minimally invasive treatments, aligning with its mission to elevate medical standards globally.

As the field of men’s healthcare continues to evolve, Olympus remains at the forefront, ensuring patients and healthcare providers alike benefit from advanced treatment options that prioritize comfort, safety, and efficacy.

For more detailed information on the iTind procedure and its benefits, visit the official iTind Procedure webpage.